Bend Bioscience is a leading small molecule contract development and manufacturing organization (CDMO) supporting pharmaceutical partners across the full drug development and manufacturing lifecycle, from preclinical research and development through clinical and commercial-scale manufacturing. Guided by its High Science + High Service philosophy, Bend combines deep scientific expertise with a broad portfolio of oral drug delivery technologies, including bioavailability enhancement, modified release, spray dried dispersions, particle engineering, and multiparticulate dosage forms. Through an integrated network of U.S. facilities, Bend delivers customized development and manufacturing solutions designed to address complex formulation challenges, optimize product performance, and support a seamless path from early development to commercial production. By combining the capabilities of a large CDMO with the agility and responsiveness of a specialized partner, Bend helps pharmaceutical innovators maximize the potential of their molecules.

For more information, visit www.bendbioscience.com.